Over 170 delegates will represent leading biotech companies, global pharma organisations and internationally renowned academic institutions.
Over 20 presentations, case studies and panel discussions will focus on the key issues in cell & gene therapy, from development and bioprocessing optimisation to commercial production.
Over two days, the congress will attract senior-level decision makers working at the forefront of the cell therapy industry from the US and Europe. The conference programme consists of world-class keynote addresses, industry and academic led presentations and panel debates, as well as ample networking opportunities, creating an interactive platform for high-level scientific and business discussion.
This event will be co-located with our prestigious 4th Annual Cell Culture & Bioprocessing Congress, as well the 2nd Annual Stem Cell Congress.